常用和新方法的比较,以确定小分子与人肝微小细胞的非特异性结合
Ting Wang1, Andrea Whitcher-Johnstone2, Young Sun Scaringella3
1Department of Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals Inc., 900 Ridgebury Rd., Ridgefield, CT 06877, USA.
Journal of pharmaceutical sciences
|April 14, 2024
概括
测量药物与人肝显微体 (HLM) 结合的不同方法在低结合性方面产生了相似的结果. 然而,显著的药物-HLM结合导致各种方法的自由分数值 (f_u,mic) 大幅变化.
科学领域:
- 药理动力学 药理动力学
- 药物新陈代谢 药物新陈代谢
- 生物化学 生物化学
背景情况:
- 准确测量非特异性药物与人肝显微体 (HLM) 的结合对于确定酶动力学参数至关重要.
- 有几种方法可以量化这种结合,包括RED,UF,HLM珠,UC,LESA和TransilTM.
研究的目的:
- 评估不同的方法是否能产生类似的自由分数 (f_u,mic) 值.
- 评估不同HLM度对不同方法中的f_u,mic测量的一致性的影响.
主要方法:
- 测试了一组具有不同HLM结合亲和力的9种化合物.
- 自由分数值 (f_u,mic) 使用六种不同的测试格式来确定.
- 在三个HLM度 (0.025,0.50和1.0毫克/毫升) 中,在单个化合物度 (1.0微米) 上进行测量.
主要成果:
- 所有测试方法都产生了相似的f_u,mic值,当药物与HLM的结合率低时 (高f_u,mic).
- 当药物与HLM的结合显著时 (低f_u,mic),f_u,mic值变化很大,方法之间的差异高达33倍.
- 在高HLM结合的情况下,测量方法的选择显著影响f_u,mic的确定.
结论:
- 假设方法独立的fu,mic值仅适用于低药物-HLM结合.
- 在高结合条件下,f_u,mic测量的差异可能会影响酶动力学参数确定的准确性.
- 这些变异对预测临床药物相互作用 (DDI) 有潜在的影响.
相关概念视频
Protein-Drug Binding: Determination Methods
174
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
174
Hepatic Drug Clearance: Effect of Protein Binding
194
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
194


